Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial
N Padayatchi, SS Abdool Karim, K Naidoo, A Grobler, G Friedland
The International Journal of Tuberculosis and Lung Disease | INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D) | Published : 2014
Awarded by US President's Emergency Plan for AIDS Relief (PEPFAR, Washington DC, USA)
Awarded by Comprehensive International Program of Research on AIDS (CIPRA)
Awarded by Fogarty International Center, NIH
This work was supported by the US President's Emergency Plan for AIDS Relief (PEPFAR, Washington DC, USA), which funded the care of all the participants in the trial (grant# 5U26PS001350); the Global Fund to Fight AIDS, Tuberculosis and Malaria (Geneva, Switzerland) funded the cost of the drugs used in the trial. The research infrastructure to conduct this trial, including data management, and laboratory and pharmacy cores were established through the Comprehensive International Program of Research on AIDS (CIPRA; grant # AI51794). CAPRISA was established as part of CIPRA from the US NIH. NP, AG and KN were supported by the Columbia University-Southern African Fogarty AIDS International Training and Research Program, funded by the Fogarty International Center, NIH (grant # D43TW00231).